Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
For the six months, sales was EUR 48.12 million compared to EUR 53.53 million a year ago. Net loss was EUR 0.729 million compared to net income of EUR 2.6 million a year ago. Basic loss per share from continuing operations was EUR 0.13 compared to basic earnings per share from continuing operations of EUR 0.37 a year ago. Diluted loss per share from continuing operations was EUR 0.13 compared to diluted earnings per share from continuing operations of EUR 0.37 a year ago.